Evidence map›Paper›PMID 25539809›Full record

ArticleParticle and fibre toxicology2014

In vitro investigation of silica nanoparticle uptake into human endothelial cells under physiological cyclic stretch.

Christian Freese, Daniel Schreiner, Laura Anspach, Christoph Bantz, Michael Maskos, Ronald E Unger, C James Kirkpatrick

Abstract readComparative Study
In one paragraph

Article in Particle and fibre toxicology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Biomechanics-mediated endocytosis in atherosclerosis.Frontiers in cardiovascular medicine · 2024
    Review
  6. Article
  7. A multiplex inhalation platform to modelFrontiers in pharmacology · 2023
    Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Christian FreeseREPAIR-lab, Institute of Pathology, University Medical Center of the Johannes Gutenberg University Mainz, European Institute of Excellence on Tissue Engineering and Regenerative Medicine, Mainz, Germany. freesec@uni-mainz.de.
Daniel SchreinerREPAIR-lab, Institute of Pathology, University Medical Center of the Johannes Gutenberg University Mainz, European Institute of Excellence on Tissue Engineering and Regenerative Medicine, Mainz, Germany. daniel_schreiner@yahoo.de.
Laura AnspachREPAIR-lab, Institute of Pathology, University Medical Center of the Johannes Gutenberg University Mainz, European Institute of Excellence on Tissue Engineering and Regenerative Medicine, Mainz, Germany. anspach@uni-mainz.de.
Christoph BantzFraunhofer ICT-IMM, Mainz, Germany. Christoph.Bantz@imm.fraunhofer.de.
Michael MaskosFraunhofer ICT-IMM, Mainz, Germany. maskos@uni-mainz.de.
Ronald E UngerREPAIR-lab, Institute of Pathology, University Medical Center of the Johannes Gutenberg University Mainz, European Institute of Excellence on Tissue Engineering and Regenerative Medicine, Mainz, Germany. runger@uni-mainz.de.
C James KirkpatrickREPAIR-lab, Institute of Pathology, University Medical Center of the Johannes Gutenberg University Mainz, European Institute of Excellence on Tissue Engineering and Regenerative Medicine, Mainz, Germany. kirkpatrick@uni-mainz.de.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIn general the prediction of the toxicity and therapeutic efficacy of engineered nanoparticles in humans is initially determined using in vitro static cell culture assays. However, such test systems may not be sufficient for testing nanoparticles intended for intravenous application. Once injected, these nanoparticles are caught up in the blood stream in vivo and are therefore in continuous movement. Physical forces such as shear stress and cyclic stretch caused by the pulsatile blood flow are known to change the phenotype of endothelial cells which line the luminal side of the vasculature and thus may be able to affect cell-nanoparticle interactions.

methodsIn this study we investigated the uptake of amorphous silica nanoparticles in primary endothelial cells (HUVEC) cultured under physiological cyclic stretch conditions (1 Hz, 5% stretch) and compared this to cells in a standard static cell culture system. The toxicity of varying concentrations was assessed using cell viability and cytotoxicity studies. Nanoparticles were also characterized for the induction of an inflammatory response. Changes to cell morphology was evaluated in cells by examining actin and PECAM staining patterns and the amounts of nanoparticles taken up under the different culture conditions by evaluation of intracellular fluorescence. The expression profile of 26 stress-related was determined by microarray analysis.

resultsThe results show that cytotoxicity to endothelial cells caused by silica nanoparticles is not significantly altered under stretch compared to static culture conditions. Nevertheless, cells cultured under stretch internalize fewer nanoparticles. The data indicate that the decrease of nanoparticle content in stretched cells was not due to the induction of cell stress, inflammation processes or an enhanced exocytosis but rather a result of decreased endocytosis.

conclusionsIn conclusion, this study shows that while the toxic impact of silica nanoparticles is not altered by stretch this dynamic model demonstrates altered cellular uptake of nanoparticles under physiologically relevant in vitro cell culture models. In particular for the development of nanoparticles for biomedical applications such improved in vitro cell culture models may play a pivotal role in the reduction of animal experiments and development costs.

Indexed as

Models, BiologicalBiological TransportCells, CulturedCell SurvivalCytokinesEndocytosisEndothelium, VascularExocytosisGene Expression ProfilingGene Expression RegulationHumansHuman Umbilical Vein Endothelial CellsKineticsNanoparticlesOligonucleotide Array Sequence AnalysisParticle SizeCytokinesSilicon Dioxide

Identifiers

PMID25539809
PMCPMC4318365

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.